Leap Therapeutics | ARS:年度报告
04/30 04:48
Leap Therapeutics | DEFA14A:其他
04/30 04:42
Leap Therapeutics | DEF 14A:股东委托书决议
04/30 04:40
Leap Therapeutics | SC 13G:超过5%持股股东披露文件-Samsara BioCapital, L.P.(6.4%),Samsara BioCapital GP, LLC(6.4%)等
04/26 08:41
Leap Therapeutics | 3:首次持股声明-股东 GILEAD SCIENCES, INC.
04/20 04:36
Leap Therapeutics | SC 13G:超过5%持股股东披露文件-Gilead Sciences, Inc.(13.9%)
04/20 04:36
Leap Therapeutics | 8-K:重大事件
04/11 20:44
Leap Therapeutics | S-3:特定交易注册声明
03/18 19:44
Leap Therapeutics | 8-K:Leap Therapeutics公布2023年第四季度和全年财务业绩
03/18 19:14
Leap Therapeutics | 10-K:年度报表
03/18 18:54
Leap Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Perceptive Advisors LLC(4.0%),Joseph Edelman(4.0%)等
02/15 05:53
Leap Therapeutics | 4:持股变动声明-董事 Mashiach Nissim
02/01 10:38
Leap Therapeutics | 4:持股变动声明-董事 Dietz Thomas John
02/01 10:38
Leap Therapeutics | 4:持股变动声明-董事 Schilsky Richard
02/01 10:38
Leap Therapeutics | 4:持股变动声明-高管 Granfield Christine
02/01 10:38
Leap Therapeutics | 4:持股变动声明-高管 Baum Jason
02/01 10:38
Leap Therapeutics | 4:持股变动声明-董事 Richard Christian M
02/01 10:38
Leap Therapeutics | 4:持股变动声明-高管 O'Mahony John Mark
02/01 10:38
Leap Therapeutics | 4:持股变动声明-高管 Sirard Cynthia
02/01 10:38
Leap Therapeutics | 4:持股变动声明-董事 Martin Patricia A.
02/01 10:38
暂无数据
暂无数据